Clinical Trial Risk in Non-Hodgkin's Lymphoma: Endpoint and Target Selection

• প্রধান লেখক: Jayson Lee Parker (লেখক), Zoe Yi Zhang (লেখক), Rena Buckstein (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2011-06-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Purpose. To quantify the clinical trial risk of new drug development in Non-Hodgkin's lymphoma (NHL). Risk estimates for this disease have not been reported before. Methods. We undertook a retrospective review of clinical trials in (NHL) in four subtypes to compare the success rate with the ind...